Applications of high content screening in life science research

Combinatorial Chemistry and High Throughput Screening

Volumn 12, Issue 9, 2009, Pages 870-876

  Zock, Joseph M ^a  

^a Thermo Fisher Scientific   (United States)

Author keywords

Cell signaling; High content screening; In vitro toxicology; Neurobiology; Oncology; RNAi; Stem cells; Target identification; Target validation

Indexed keywords

SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

APOPTOSIS; BIOMEDICINE; CANCER CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL RENEWAL; CELL STRUCTURE; CYTOTOXICITY; HIGH THROUGHPUT SCREENING; HUMAN; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BIOLOGICAL SCIENCE DISCIPLINES; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; RESEARCH;

EID: 70349449748     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620709789383277     Document Type: Review

References (102)

1. Harrison, B.C.; Kim, M.S., van Rooji, E.; Plato, C.F.; Papst, P.J.; Vega, R.B.; McAnally, J.A.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N.; McKinsey, T.A. Regulation of cardiac stress signaling by protein kinase D1. Mol Cell. Biol., 2006, 26(10), 3875-3888. (Pubitemid 43726404)
2. Li, Z.; Yan, Y.; Powers, E.A.; Ying, X.; Janjua, K.; Garyantes, T.; Baron, B. Identification of gap junction blockers using automated fluorescence microscopy imaging. J. Biomol. Screen. 2003, 8, 489-499. (Pubitemid 40503581)
3. Yan, P.; Nanamori, M.; Sun, M.; Zhou, C.; Cheng, N.; Li, N.; Zheng, W.; Xiao, L.; Xie, X.; Ye, R.D.; Wang, M.W. The immunosuppressant cyclosporin A antagonizes human formyl peptide receptor through inhibition of cognate ligand binding. J. Immunol., 2006, 177, 7050-7058.
4. Buckbinder, L.; Crawford, D.T.; Qi, H.; Ke, H.Z.; Olson, L.M.; Long, K.R.; Bonnette, P.C.; Baumann, A.P.; Hambor, J.E.; Grasser, W.A.; Pan, L.C.; Owen, T.A.; Luzzio, M.J.; Hulford, C.A.; Gebhard, D.F.; Paralkar, V.M.; Simmons, H.A.; Kath, J.C.; Roberts, W.G.; Smock, S.L.; Guzman-Perez, A.; Brown, T.A.; Li, M. Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation and offers an anabolic treatment approach for osteoporosis. Proc. Natl. Acad. Sci., USA, 2007, 104(25), 10619-10624. (Pubitemid 47185714)
5. Steinberg, B.E.; Scott, C.C.; Grinstein, S. High-throughput assays of phagocytosis, phagosome maturation, and bacterial invasion. Am. J. Physiol. Cell. Physiol., 2007, 292, 945-952. (Pubitemid 46263496)
6. Zhang, L.; Yu, J.; Pan, H.; Hu, P.; Hao, Y.; Cai, W.; Zhu, H.; Yu, A.D.; Xie, X.; Ma, D.; Yuan, J. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc. Natl. Acad. Sci. USA, 2007, 104(48), 19023-19028.
7. Rogers, G.C.; Rusan, N.M.; Peifer, M.; Rogers, S.L. A Multicomponent assembly pathway contributes to the formation of acentrosomal microtubule arrays in interphase drosophila cells. Mol. Biol. Cell., 2008, 19, 3163-3178.
8. Wheeler, R.T.; Fink, G.R. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog., 2006, 2(4), e35 328-339.
9. Kerrison, J.B.; Lewis, R.N.; Otteson, D.C.; Zack, D.J. Bone morphogenic proteins promote neurite outgrowth in retinal ganglion cells. Mol. Vision, 2005, 11, 208-215.
10. Badura, L.; Swanson, T.; Adamowicz, W.; Adams, J.; Cianfrogna, J.; Fisher, K.; Holland, J.; Kleiman, R.; Nelson, F.; Reynolds, L.; St. Germain, K.; Schaeffer, E.; Tate, B.; Sprouse, J. An inhibitor of casein kinase I induces phase delays in circadian rhythms under free-running and entrained conditions. J. Pharmacol. Exp. Ther., 2007, 322, 730-738.
11. Benanti, J.A.; Cheung, S.K.; Brady, M.C.; Toczyski, D.P. A proteomic screen reveals SCF[Grr1] targets that regulate the glycolytic-gluconeogenic switch. Nat. Cell Biol., 2007, 9(10), 1184-1191.
12. Gasparri, F.; Mariani, M.; Sola, F.; Galvani, A. Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high content screening reader. J. Biomol. Screen. 2004, 9, 232-243. (Pubitemid 40503554)
13. Vogt, A.; Cooley, K.A.; Brisson, M.; Tarpley, M.G.; Wipf, P.; Lazo, J.S. Cell-active dual specificity phosphatase inhibitors identified by high content screening. Chem. Biol., 2003, 10, 733-742.
14. Liu, D.; McIlvain, H.B.; Fennell, M.; Dunlop, J.; Wood, A.; Zaleska, M.M.; Graziani, E.I.; Pong, K. Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells. J. Neurosci. Methods, 2007, 163, 310-320. (Pubitemid 46874607)
15. Agler, M.; Prack, M.; Zhu, Y.; Kolb, J.; Nowak, K.; Ryseck, R.; Shen, D.; Cvijic, M.E.; Somerville, J.; Nadler, S.; Chen, T. A high content glucocorticoid receptor translocation assay for compound mechanism-of-action evaluation. J. Biomol. Screen., 2007, 12, 1029-1041. (Pubitemid 350179704)
16. Baniecki, M.L.; Wirth, D.F.; Clardy, J. High-Throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob. Agents Chemother., 2007, 51(2), 716-723.
17. Johnson, M.C.; Damon, I.K.; Karem, K.L. A Rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein. J. Virol. Methods, 2008, 150, 14-20.
18. Keefer, S.; Zock, J. In Approaching High Content Screening and Analysis: Practical Advice for Users; Haney, S.A., Eds.; High Content Screening: Science, Techniques and Applications. Wiley- Interscience, 2008, pp. 3-24.
19. Young, D.W.; Bender, A.; Hoyt, J.; McWhinnie, E.; Chirn, G.W.; Tao, C.Y.; Tallarico, J.A.; Labow, M.; Jenkins, J.L.; Mitchison, T.J.; Feng, Y. Integrating high content screening and ligand-target prediction to identify mechanism of action. Nat. Chem. Biol., 2008, 4, 59-68. (Pubitemid 350273652)
20. Ding, G.J.F.; Fischer, P.A.; Boltz, R.C.; Schmidt, J.A.; Colaianne, J.J.; Gough, A.; Rubin, R.A.; Miller, D.K. Characterization and quantitation of NF-kB nuclear translocation induced by interleukin- 1 and tumor necrosis factor-a. J. Biol. Chem., 1998, 273, 28897-28905.
21. Vakkila, J.; DeMarco, R.A.; Lotze, M.T. Imaging analysis of STAT1 and NF-kB translocation in dendritic cells at the single cell level. J. Immunol. Methods, 2004, 294, 123-134.
22. Grace, M.J.; Lee, S.; Bradshaw, S.; Chapman, J.; Spond, J.; Cox, S.; DeLorenzo, M.; Brassardi, D.; Wylie, D.; Cannon-Carlson, S.; Cullen, C.; Indelicato, S.; Voloch, M.; Bordens, R. Site of pegylation and polyethylene glycol molecule size attenuate inferferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J. Biol. Chem., 2004, 280(8), 6327-6336. (Pubitemid 40341179)
23. Borchert, K.M.; Galvin, R.J.; Frolik, C.A.; Hale, L.V.; Halladay, D.L.; Gonyier, R,J.; Trask, O.J.; Nickischer, D.R.; Houck, K.A. High content screening assay for activators of the wnt/fzd pathway in primary human cells. Assay Drug Dev. Technol., 2005, 3(2), 133-141.
24. Lundholt, B.K.; Linde, V.; Loechel, F.; Pedersen, H.C.; Moller, S.; Praestegaard, M.; Mikkelsen, I.; Scudder, K.; Bjorn, S.P.; Heide, M.; Arkhammar, P.O.; Terry, R.; Nielsen, S.J. Identification of Akt pathway inhibitors using Redistribution® screening on the FLIPR and the InCell 3000 Analyzer. J. Biomol. Screen., 2005, 10, 20-29. (Pubitemid 40503506)
25. Van Sant, C.; Wang, G.; Anderson, M.G.; Trask, O.J.; Lesniewski, R.; Semizarov, A. Endothelin signaling in osteoblasts: global genome view and implication of the calcineurin/NFAT pathway. Mol. Cancer Ther., 2007, 6(1), 253-261.
26. Ross, S.; Chen, T.; Yu, V.; Tudor, Y.; Zhang, D.; Liu, L.; Tamayo, N.; Dominguez, C.; Powers, D. High content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays. Assay Drug. Dev. Technol., 2006, 4(4), 397-409. (Pubitemid 44781631)
27. Sarker, K.P.; Kataoka, H.; Chan, A.; Netherton, S.J.; Pot, I.; Huynh, M.A.; Feng, X.; Bonni, A.; Riabowol, K.; Bonni, S. ING2 as a novel mediator of transforming growth factor-β-dependent responses in epithelial cells. J. Biol. Chem., 2008, 283, 13269-13279.
28. Dawes, L.J.; Angell, H.; Sleeman, M.; Reddan, J.R.; Wormstone, I.M. TGFb isoform dependant Smad2/3 kinetics in human lens epithelial cells: a cellomics analysis. Exp. Eye Res., 2007, 84, 1009-1012.
29. Wormstone, I.M.; Dawes, L.J.; Sleeman, M.; Anderson, I.K.; Reddan, J.R. FGF promotes TGF-beta-induced matrix contraction and suppresses expression of the transdifferentiation marker alphaSMA. Invest. Ophthalmol. Vis. Sci., 2008, 49, 3726.
30. Bertelsen, M.; Sanfridson, A. Inflammatory pathway analysis using a high content screening platform. Assay Drug Dev. Technol., 2005, 3, 261-271. (Pubitemid 41079124)
31. Schlag, B.D.; Lou, Z.; Fennell, M.; Dunlop, J. Ligand dependency of 5-HT2C receptor internalization. J. Pharmacol. Exp. Ther., 2004, 310, 865-870.
32. Fowler, A.; Seifert, N.; Acker, V.; Woehrle, T.; Kilpert, C.; de Saizieu, A. A nonradioactive high-throughput / high content assay for measurement of the human serotonin reuptake transporter function in vitro. J. Biomol. Screen. 2006, 11, 1027-1034.
33. Barnard, R.; Barnard, A.; Salmon, G.; Liu, W.; Sreckovic, S. Histamine-induced actin polymerization in human eosinophils: an imaging approach for histamine H4 receptor. Cytometry A, 2008, 73(4), 299-304.
34. Inglefield, J.R.; Larson, C.J.; Gibson, S.J.; Lebrec, H.; Miller, R.L. Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry. J. Biomol. Screen., 2006, 11(6), 575-585.
35. Lovbor, H.; Gullbo, J.; Larsson, R. Screening for apoptosis-classical and emerging techniques. Anticancer Drugs, 2005, 16, 593-599.
36. To, K.; Zhao, Y.; Jiang, H.; Hu, K.; Wang, M.; Wu, J.; Lee, C.; Yokom, W.; Stratford, A.L.; Klinge, U.; Mertens, P.R.; Chen, C.S.; Bally, M.; Yapp, D.; Dunn, S.E. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl0-3-(trifluoromethyl)-1hH-pyrazol-1-yl]phenyl] -acetamide (OSU- 03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor. Mol. Pharmacol., 2007, 72(3), 641-652.
37. Vogt, A.; McDonald, P.R.; Tamewitz, A.; Sikorski, R.P.; Wipf, P.; Skoko, III J.J.; Lazo, J.S. A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells. Mol. Cancer Ther., 2008, 7, 330-340.
38. Cummings, J.; Hodgkinson, C.; Odedra, R.; Sini, P.; Heaton, S.P.; Mundt, K.E.; Ward, T.H.; Wilkinson, R.W.; Growcott, J.; Hughes, A.; Dive, C. Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity. Mol. Cancer Ther., 2008, 7, 455-463.
39. Soncini, C.; Carpinelli, P.; Gianellini, L.; Fancelli, D.; Vianello, P.; Rusconi, L.; Storici, P.; Zugnoni, P.; Pesenti, E.; Croci, V.; Ceruti, R.; Giorgini, M.L.; Cappella, P.; Ballinari, D.; Sola, F.; Varasi, M.; Bravo, R.; Moll, J. PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity. Clin. Cancer Res., 2006, 12(13), 4080-4089. (Pubitemid 44078096)
40. Gasparri, F.; Mariani, M.; Sola, F.; Galvani, A. Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high content screening reader. J. Biomol. Screen., 2004, 9, 232-243. (Pubitemid 40503554)
41. Breier, J.M.; Radio, N.M.; Mundy, W.R.; Shafer, T.J. Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol. Sci., 2008, 105, 119-133.
42. Barabasz, A.; Foley, B.; Otto, J.C.; Scott, A.; Rice, J. The use of high content screening for the discovery and characterization of compounds that modulate mitotic index and cell cycle progression by differing mechanisms of action. Assay Drug Dev. Technol., 2006, 4(2), 153-163. (Pubitemid 43810919)
43. Gasparri, F.; Ciavolella, A.; Galvani, A. Cell cycle inhibitor profiling by high content analysis. Adv. Exp. Med. Biol., 2007, 604, 137-148.
44. Gasparri, F.; Cappella, P.; Galvani, A. Multiparametric cell cycle analysis by automated microscopy. J. Biomol. Screen., 2006, 11, 586-598. (Pubitemid 44315956)
45. Li, Y.; Pan, J.; Li, J.L.; Lee, J.H.; Tunkey, C.; Saraf, K.; Garbe, J.C.; Whitley, M.Z.; Jelinsky, S.A.; Stampfer, M.R.; Haney, S.A. Transcriptional changes associate with breast cancer occur as normal human mammary epithelial cells overcome senescence barrier and become immortalized. Mol. Cancer, 2007, 6(7), 1-17.
46. Mastyugin, V.; McWhinnie, E.; Labow, M.; Buxton, F. A quantitative high-throughput endothelial cell migration assay. J. Biomol. Screen., 2004, 9, 712-718. (Pubitemid 40491155)
47. Richards, G.R.; Millard, R.M.; Leveridge, M.; Kerby, J.; Simpson, P.B. Quantitative assays of chemotaxis and chemokinesis for human neural cells. Assay Drug Dev. Technol., 2004, 2, 465-472.
48. Nam, J.-S.; Ino, Y.; Kanai, Y.; Sakamoto, M.; Hirohashi, S. 5-aza- 2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. Clin. Exp. Metastasis, 2004, 21, 49-56. (Pubitemid 38365657)
49. Bhawe, K.M.; Blake, R.A..; Clary, D.O.; Flanagan, P.M. An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation. J. Biomol. Screen. 2004, 9, 216-222. (Pubitemid 40503552)
50. Shimamra, T.; Yasuda, J.; Ino, Y.; Gotoh, M.; Tsuchiya, A.; Nakajima, A.; Sakamoto, M.; Kanai, Y.; Hirohashi, S. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res., 2004, 64, 6989-6995. (Pubitemid 39331008)
51. Chuma, M.; Sakamoto, M.; Yasuda, J.; Fujii, G.; Nakanishi, K.; Tsuchiya, A.; Ohta, T.; Asaka, M.; Hirohashi, S. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J. Hepatol., 2004, 41, 629-636.
52. O'Brien, C.; Cavet, G.; Pandita, A.; Hu, X.; Haydu, L.; Mohan, S.; Toy, K.; Rivers, C.S.; Modrusan, Z.; Amler, L.C.; Lackner, M.R. Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res., 2008, 68, 5380-5389.
53. Sartore-Bianchi, A.; Gasparri, F.; Galvani, A.; Nici, L.; Darnowski, J.W.; Barbone, D.; Fennell, D.A.; Gaudino, G.; Porta, C.; Mutti, L. Bortezomib inhibits nuclear factor-kappa B dependent survival and has potent in vivo activity in mesothelioma. Clin. Cancer Res., 2007, 13(19), 5942-5951. (Pubitemid 47583922)
54. Liu, L.; Cao, Y.; Chen, C.; Zhang, X.; McNabola, A.; Wilkie, D.; Wilhelm, S.; Lynch, M.; Carter, C. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res., 2006, 66(24), 11851-11858. (Pubitemid 46094197)
55. Basu, P.; Ghosh, R.; Grove, L.; Klei, L.; Barchowsky, A. Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic acid (Roxarsone). Environ. Health Perspect., 2008, 114(4), 520-523. (Pubitemid 351864313)
56. Wei, S.Y.; Li, M.; Tang, S.A.; Sun, W.; Xu, B.; Cui, J.R.; Lin, W.H. Induction of apoptosis accompanying with G1 phase arrest and microtubule disasembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene. Cancer Lett., 2008, 262, 114-122.
57. Minguez, J.M.; Giuliano, K.A.; Balachandran, R.; Madiraju, C.; Curran, D.P.; Day, B.W. Synthesis and high content cell-based profiling of simplified analogues of the microtubule stabilizer (+)- discodermolide. Mol. Cancer Ther., 2002, 1, 1305-1313.
58. Tolliday, N.; Clemens, P.A.; Ferraiolo, P.; Koehler, A.N.; Lewis, T.A.; Li, X.; Schreiber, S.L.; Gerhard, D.S.; Eliasof, S. Small molecules, big players: the National Cancer Institute's initiative for chemical genetics. Cancer Res., 2006, 66(18), 8935-8942. (Pubitemid 44521107)
59. Richards, G.R.; Smith, A.J.; Parry, F.; Platts, A.; Chan, G.K.; Leveridge, M.; Kerby, J.E.; Simpson, P.B. A morphology- and kinetics-based cascade for human neural cell high content screening. Assay Drug Dev. Technol., 2006, 4(2), 143-152.
60. McIlvain, H.B.; Baudy, A.; Sullivan, K.; Liu, D.; Pong, K.; Fennell, M.; Dunlop, J. Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathway. Brain Res., 2006, 1077(1), 16-23.
61. Loh, S.H.; Francescut, L.; Lingor, P.; Bahr, M.; Nicotera, P. Identification of new kinase clusters required for neurite outgrowth and retraction by loss-of-function RNA interference screen. Cell Death Differ., 2008, 15(2), 283-298.
62. Qian, M.D.; Zhang, J.; Tan, X.Y.; Wood, A.; Gill, D.; Cho, S. Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities. J. Neurosci., 2006, 26, 9394-9403. (Pubitemid 44396852)
63. Zhou, W.; Zhu, X.; Zhu, L.; Cui, Y.Y.; Wang, H.; Qi, H.; Ren, Q.S.; Chen, H.Z. Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons. Cell. Mol. Neurobiol., 2008, 28, 263-275.
64. Ruan, B.; Pong, K.; Jow, F.; Bowlby, M.; Crozier, R.A.; Liu, D.; Liang, S.; Chen, Y.; Mercado, M.L.; Feng, X.; Bennett. F.; von Schack, D.; McDonald, L.; Zaleska, M.M.; Wood, A.; Reinhart, P.H.; Magola, R.L.; Skotnicki, J.; Pangalos, M.N.; Koehn, F.E.; Carter, G.T.; Abou-Gharbia, M.; Graziani, E.I. Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities. Proc. Natl. Acad. Sci. USA, 2008, 105(1), 33-38.
65. Fennell, M.; Chan, H.; Wood, A. Multiparameter measurement of caspase 3 activation and apoptotic cell death in NT2 neuronal precursor cells using high content analysis. J. Biomol. Screen., 2006, 11(3), 296-302.
66. Culbert, A.A.; Skaper, S.D.; Howlett, D.R.; Evans, N.A.; Facci, L.; Soden, P.E.; Seymour, Z.M.; Guillot, F.; Gaestel, M.; Richardson, J.C. MAPK-activated protein kinase 2 deficiency in micoglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: relevance to neuroinflammation in a transgenic mouse model of Alzheimer Disease. J. Biol. Chem., 2006, 281(33), 23658-23667.
67. Lotharius, J.; Falsig, J.; van Beek, J.; Payne, S.; Dringen, R.; Brundin, P.; Leist, M. Progressive degenration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on a mixed-lineage kinase pathway. J. Neurosci., 2005, 25(27), 6329-6342. (Pubitemid 40962528)
68. Plun-Favreau, H.; Klupsch, K.; Moisoi, N.; Gandhi, S.; Kjaer, S.; Frith, D.; Harvey, K.; Deas, E.; Harvey, R.J.; McDonald, N.; Wood, N.W.; Martins, L.M.; Downward, J. The mitochondrial protease HtrA2 is regulated by Parkinson's Disease-associated linase PINK1. Nat. Cell Biol., 2007, 9(11), 1227-1229. (Pubitemid 350042356)
69. Doi, H.; Okamura, K.; Bauer, P.O.; Furukawa, Y.; Shimizu, H.; Kurosawa, M.; Machida, Y.; Miyazaki, H.; Mitsui, K.; Kuriowa, Y.; Nukina. N. RNA-binding protein TLS is a major nuclear aggregate-interacting proein in Huntingtin exon 1 with expanded polyglutamine-expressing cells. J. Biol. Chem., 2007, 283(10), 6489-6500.
70. Rigamonti, D.; Bolognini, D.; Mutti, C.; Zuccato, C.; Tartari, M.; Sola, F.; Valenza, M.; Kazantsev, A.G.; Cattaneo, E. Loss of Huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators J. Biol. Chem., 2007, 282, 24554-24562. (Pubitemid 47347498)
71. Furukawa, Y.; Kaneko, K.; Yamanaka, K.; O'Halloran, T.V.; Nukina, N. Complete loss of post-translational modifications triggers fibrillar aggregation of sod1 in familial form of ALS. JBC manuscript M802083200. J. Biol. Chem., 2008, 283(35), 24167-24176.
72. Wickstrom, M.; Johnsen, J.I.; Ponthan, F.; Segerstrom, L.; Sveinbjornsson, B.; Lindskog, M.; Lovborg, H.; Viktorsson, K.; Lewensohn, R.; Kogner, P.; Larsson, R.; Gullbo, J. The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo. Mol. Cancer Ther., 2007, 6, 2409-2417. (Pubitemid 47480406)
73. Dykens, J.A.; Jamieson, J.D.; Marroquin, L.D.; Nadanaciva, S.; Xu, J.J.; Dunn, M.C.; Smith, A.R.; Will, Y. In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. Toxicol. Sci., 2008, 103(2), 335-345 (Pubitemid 351659605)
74. Bova, M.P.; Tam, D.; McMahon, G.; Mattson, M.N. Troglitaone induces a rapid drop of mitochodrial membrane potential in liver HepG2 cells. Tox. Lett., 2005, 155, 41-50.
75. Xu, J.J.; Dunn, M.C.; Smith, A. Applications of cell based imaging technologies in toxicity screening in drug discovery and development. American Drug Discov., 2006, 1(1), 20-26.
76. Jeffrey, K.D.; Alejandro, E.U.; Luciani, D.S.; Kalynyak, T.B.; Hu, X.; Li, H.; Lin, Y.; Townsend, R.R.; Polonsky, K.S.; Johnson, J.D. Carboxypeptidase E mediates palmitate-induced β-cell ER stress and apoptosis. Proc. Natl. Acad. Sci. USA, 2008, 105, 8452-8457. (Pubitemid 351904777)
77. Diaz, D.; Scott, A.; Carmichael, P.; Shi, W.; Costales, C. Evaluation of an automated in vitro micronucleus assay in CHOK1 cells. Mutat. Res., 2007, 630(1-2), 1-13. (Pubitemid 46756387)
78. Scott, A.; Malcomber, S.; Maskell, S.; Moore, C.; Windebank, S.; Diaz, D.; Carmichael, P. An assessment of the performance of an automated scoring system (Cellomics) for the in vitro micronucleus assa in CHO-K1 cells. Toxicology, 2007, 231(2-3), 111-112.
79. Morelli, J.K.; Buehrle, M.; Pognan, F.; Barone, L.R.; Fieles, W.; Ciaccio, P.J. Validation of an in vitro screen for phospholipidosis using a high content biology platform. Cell. Biol. Toxicol., 2006, 22(1), 15-27.
80. Radio, N.M.; Breier, J.M.; Shafer, T.J.; Mundy, W.R. Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. Toxicol. Sci., 2008, 105, 106-118.
81. Yu, X.; Sidhu, J.S.; Hong, S.; Faustman, E.M. Essential role of extracellular matrix overlay in establishing the functional integrity of primary neonatal rat sertoli cell/gonocyte cocultures: an improved in vitro model for assessment of male reproductive toxicity. Toxicol. Sci., 2005, 84, 378-393.
82. Xu, J.J.; Henstock, P.V.; Dunn, M.C.; Smith, A.R.; Chabot, J.R.; de Graaf, D. Cellular imaging predictions of clinical drug-induced liver injury. Toxicolog. Sci., 2008, 105(1), 97-105
83. O'brien, P.J.; Irwin, W.; Diaz, D.; Howard-Cofield, E.; Krejsa, C.M.; Slaughter, M.R.; Gao, B.; Kaludercic, N.; Angeline, A.; Bernardi, P.; Brain, P.; Hougham, C. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol., 2006, 80(9), 580-604.
84. Abraham, V.C.; Towne, D.L.; Waring, J.F.; Warrior, U.; Burns, D.J. Application of a high content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans. J. Biomol. Screen., 2008, 13, 527-537.
85. Perrimon, N.; Mathey-Prevot, B. Applications of high-throughput RNA interference screens to problems in cell and developmental biology. Genetics, 2007, 175, 7-16. (Pubitemid 46168551)
86. Moffat, J.; Grueneberg, D.A.; Yang, X.; Kim, S.Y.; Kloepfer, A.M.; Hinkle, G.; Piqani, B.; Eisenhaure, T.M.; Luo, B.; Grenier, J.K.; Carpenter, A.E.; Foo, S.Y.; Stewart, S.A.; Stockwell, B.R.; Hacohen, N.; Hahn, W.C.; Lander, E.S.; Sabatini, D.M.; Root, D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high content screen. Cell, 2006, 24, 1283-1298.
87. Björklund, M.; Taipale, M.; Varjosalo, M.; Saharinen, J.; Lahdenperä, J.; Taipale, J. Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature, 2006, 439, 1009-1013. (Pubitemid 43292422)
88. Low, J.; Huang, S.; Dowless, M.; Blosser, W.; Vincent, T.; Davis, S.; Hodson, J.; Koller, E.; Marcusson, E.; Blanchard, K.; Stancato, L. High content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotides. J. Biomol. Screen., 2007, 12(6), 775-788. (Pubitemid 47340698)
89. Xin, H.; Bernal, A.; Amato, F.A.; Pinhasov, A.; Kauffman, J.; Brenneman, D.E.; Derian, C.K.; Andrade-Gordon, P.; Plata- Salamán, C.R.; Ilyin, S.E. High-throughput siRNA-based functional target validation. J. Biomol. Screen. 2004, 9(4), 286-293. (Pubitemid 40503540)
90. Trammell, M.A.; Mahoney, N.M.; Agard, D.A.; Vale, R.D. Mob4 plays a role in spindle focusing in Drosophila S2 cells. J. Cell Sci., 2008, 121, 1284-1292.
91. Walker, E.; Ohishi, M.; Davey, R.E.; Zhang, W.; Cassar, P.A.; Tanaka, T.S.; Der, S.D.; Morris, Q.; Hughes, T.R.; Zandstra, P.W.; Stanford, W.L. Prediction and testing of novel transcription networks regulating embryonic stem cell self-renewal and commitment. Stem Cell, 2007, 1, 71-86.
92. Davey, R.E.; Onishi, K.; Mahdavi, A.; Zandstra, P.W. LIF-mediated control of embryonic stem cell self-renewal emerges due to an autoregulatory loop. FASEB J., 2007, 21(9), 2020-2032.
93. Bauwens, C.L.; Peerani, R.; Niebruegge, S.; Woodhouse, K.A.; Kumacheva, E.; Husain, M.; Zandstra, P.W. Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells, 2008, 26(9), 2300-2310.
94. Cole, M.F.; Johnstone, S.E.; Newman, J.J.; Kagey, M.H.; Young, R.A. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev., 2008, 22, 746-755.
95. Tay, Y.M.; Tam, W.L.; Ang, Y.S.; Gaughwin, P.M.; Yang, H.H.; Wang, W.; Liu, R.; George, J.; Ng, H.H.; Perera, R.J.; Lufkin, T.; Rigoutsos, I.; Thomson, A.M.; Lim, B. MicroRNA-134 modulates the differentiation of mouse embryonic stem cells where it cuses post-transcriptional attenuation of naog and LRH1. Stem Cells, 2007, 26(1), 17-29.
96. Lawrence, J.M.; Singhal, S.; Bhatia, B.; Keegan, D.J.; Reh, T.A.; Luthert, P.J.; Khaw, P.T.; Limb, G.A. MIO-M1 cells aand similar Muller glial cell lines derived from adult human retina exhibit neural stem cell characteristics. Stem Cells, 2007, 25, 2033-2043.
97. Arrell, D.K.; Niederlander, N.J.; Faustino, R.S.; Behfar, A.; Terzic, A. Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of TNFα-primed endodermal secretome. Stem Cells, 2007, 26, 387-400.
98. Peerani, R.; Rao, B.M.; Bauwens, C.; Yin, T.; Wood, G.A.; Nagy, A.; Kumacheva, E.; Zandstra, P.W. Niche-mediated control of human embryonic stem cell self-renewal and diferentiation. EMBO J., 2007, 26, 4744-4755. (Pubitemid 350126801)
99. Cappella, P.; Gasparri, F.; Pulici, M.; Moll, J. A novel method based on click chemistry which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A, 2008, 73(7), 626-636. (Pubitemid 351930749)
100. Lamian, V.; Rich, A.; Ma, Z.; Li, J.; Seethala, R.; Gordon, D.; Dubaquie, Y. Characterization of agonist-induced motilin receptor trafficking and its implications for tachyphylaxis. Mol. Pharmacol., 2006, 69, 109-118. (Pubitemid 43048898)
101. The Committee on Toxicity Testing and Assessment of Environmental Agents Toxicity testing in the 21 century: a vision and a strategy. Natl. Res. Council, 2007 ISBN: 0-3-9-10993-0, 216 pages.
102. NICEATM and ICCVAM The NICEATM-ICCVAM five year plan: a plan to advance alternative test methods of high scientific quality to protect and advance the health of people, animals, and the environment. 2008 NIH Publication No. 08-6410, 59 pages.